How do stimulant treatments for ADHD work? Evidence for mediation by improved cognition

Larry W. Hawk, Whitney D. Fosco, Craig R. Colder, James Waxmonsky, William E. Pelham, Keri S. Rosch

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Stimulant medications such as methylphenidate (MPH) are the frontline treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). Despite their well-documented efficacy, the mechanisms by which stimulants improve clinical outcomes are not clear. The current study evaluated whether MPH effects on classroom behavior were mediated by improved cognitive functioning. Methods: Children with ADHD (n = 82; 9–12 years old) participated in a week-long summer research camp, consisting of cognitive testing, classroom periods, and recreational activities. After a baseline day, participants completed a 3-day randomized, double-blind, placebo-controlled trial of MPH (at doses approximating 0.3 and 0.6 mg/kg of immediate-release MPH dosed TID). Cognitive domains included inhibitory control (Stop Signal Task and prepulse inhibition of startle), attention (Continuous Performance Task and reaction time variability), and working memory (forward and backward spatial span). Clinical outcomes included math seatwork productivity and teacher-rated classroom behavior. A within-subjects path-analytic approach was used to test mediation. MPH-placebo and dose–response contrasts were used to evaluate drug effects. Results: Methylphenidate improved seatwork productivity and teacher ratings (ds = 1.4 and 1.1) and all domains of cognition (ds = 0.3–1.1). Inhibitory control (Stop Signal Task, SST) and working memory backward uniquely mediated the effect of MPH (vs. placebo) on productivity. Only working memory backward mediated the impact of MPH on teacher-rated behavior. The dose–response (0.6 vs. 0.3 mg/kg) effects were more modest for clinical outcomes (ds = 0.4 and 0.2) and cognition (ds = 0–0.3); there was no evidence of cognitive mediation of the clinical dose–response effects. Conclusions: These findings are novel in demonstrating that specific cognitive processes mediate clinical improvement with stimulant treatment for ADHD. They converge with work on ADHD theory, neurobiology, and treatment development in suggesting that inhibitory control and working memory may be mechanisms of stimulant treatment response in ADHD. More work is necessary to evaluate the degree to which these findings generalize to chronic treatment, a broader array of clinical outcomes, and nonstimulant treatments.

Original languageEnglish (US)
Pages (from-to)1271-1281
Number of pages11
JournalJournal of Child Psychology and Psychiatry and Allied Disciplines
Volume59
Issue number12
DOIs
StatePublished - Dec 1 2018

Fingerprint

Methylphenidate
Attention Deficit Disorder with Hyperactivity
Cognition
Short-Term Memory
Placebos
Therapeutics
Efficiency
Neurobiology
Task Performance and Analysis
Reaction Time

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Developmental and Educational Psychology
  • Psychiatry and Mental health

Cite this

Hawk, Larry W. ; Fosco, Whitney D. ; Colder, Craig R. ; Waxmonsky, James ; Pelham, William E. ; Rosch, Keri S. / How do stimulant treatments for ADHD work? Evidence for mediation by improved cognition. In: Journal of Child Psychology and Psychiatry and Allied Disciplines. 2018 ; Vol. 59, No. 12. pp. 1271-1281.
@article{f065b000ceea4855b656a4e1ba476236,
title = "How do stimulant treatments for ADHD work? Evidence for mediation by improved cognition",
abstract = "Background: Stimulant medications such as methylphenidate (MPH) are the frontline treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). Despite their well-documented efficacy, the mechanisms by which stimulants improve clinical outcomes are not clear. The current study evaluated whether MPH effects on classroom behavior were mediated by improved cognitive functioning. Methods: Children with ADHD (n = 82; 9–12 years old) participated in a week-long summer research camp, consisting of cognitive testing, classroom periods, and recreational activities. After a baseline day, participants completed a 3-day randomized, double-blind, placebo-controlled trial of MPH (at doses approximating 0.3 and 0.6 mg/kg of immediate-release MPH dosed TID). Cognitive domains included inhibitory control (Stop Signal Task and prepulse inhibition of startle), attention (Continuous Performance Task and reaction time variability), and working memory (forward and backward spatial span). Clinical outcomes included math seatwork productivity and teacher-rated classroom behavior. A within-subjects path-analytic approach was used to test mediation. MPH-placebo and dose–response contrasts were used to evaluate drug effects. Results: Methylphenidate improved seatwork productivity and teacher ratings (ds = 1.4 and 1.1) and all domains of cognition (ds = 0.3–1.1). Inhibitory control (Stop Signal Task, SST) and working memory backward uniquely mediated the effect of MPH (vs. placebo) on productivity. Only working memory backward mediated the impact of MPH on teacher-rated behavior. The dose–response (0.6 vs. 0.3 mg/kg) effects were more modest for clinical outcomes (ds = 0.4 and 0.2) and cognition (ds = 0–0.3); there was no evidence of cognitive mediation of the clinical dose–response effects. Conclusions: These findings are novel in demonstrating that specific cognitive processes mediate clinical improvement with stimulant treatment for ADHD. They converge with work on ADHD theory, neurobiology, and treatment development in suggesting that inhibitory control and working memory may be mechanisms of stimulant treatment response in ADHD. More work is necessary to evaluate the degree to which these findings generalize to chronic treatment, a broader array of clinical outcomes, and nonstimulant treatments.",
author = "Hawk, {Larry W.} and Fosco, {Whitney D.} and Colder, {Craig R.} and James Waxmonsky and Pelham, {William E.} and Rosch, {Keri S.}",
year = "2018",
month = "12",
day = "1",
doi = "10.1111/jcpp.12917",
language = "English (US)",
volume = "59",
pages = "1271--1281",
journal = "Journal of Child Psychology and Psychiatry and Allied Disciplines",
issn = "0021-9630",
publisher = "Wiley-Blackwell",
number = "12",

}

How do stimulant treatments for ADHD work? Evidence for mediation by improved cognition. / Hawk, Larry W.; Fosco, Whitney D.; Colder, Craig R.; Waxmonsky, James; Pelham, William E.; Rosch, Keri S.

In: Journal of Child Psychology and Psychiatry and Allied Disciplines, Vol. 59, No. 12, 01.12.2018, p. 1271-1281.

Research output: Contribution to journalArticle

TY - JOUR

T1 - How do stimulant treatments for ADHD work? Evidence for mediation by improved cognition

AU - Hawk, Larry W.

AU - Fosco, Whitney D.

AU - Colder, Craig R.

AU - Waxmonsky, James

AU - Pelham, William E.

AU - Rosch, Keri S.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Background: Stimulant medications such as methylphenidate (MPH) are the frontline treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). Despite their well-documented efficacy, the mechanisms by which stimulants improve clinical outcomes are not clear. The current study evaluated whether MPH effects on classroom behavior were mediated by improved cognitive functioning. Methods: Children with ADHD (n = 82; 9–12 years old) participated in a week-long summer research camp, consisting of cognitive testing, classroom periods, and recreational activities. After a baseline day, participants completed a 3-day randomized, double-blind, placebo-controlled trial of MPH (at doses approximating 0.3 and 0.6 mg/kg of immediate-release MPH dosed TID). Cognitive domains included inhibitory control (Stop Signal Task and prepulse inhibition of startle), attention (Continuous Performance Task and reaction time variability), and working memory (forward and backward spatial span). Clinical outcomes included math seatwork productivity and teacher-rated classroom behavior. A within-subjects path-analytic approach was used to test mediation. MPH-placebo and dose–response contrasts were used to evaluate drug effects. Results: Methylphenidate improved seatwork productivity and teacher ratings (ds = 1.4 and 1.1) and all domains of cognition (ds = 0.3–1.1). Inhibitory control (Stop Signal Task, SST) and working memory backward uniquely mediated the effect of MPH (vs. placebo) on productivity. Only working memory backward mediated the impact of MPH on teacher-rated behavior. The dose–response (0.6 vs. 0.3 mg/kg) effects were more modest for clinical outcomes (ds = 0.4 and 0.2) and cognition (ds = 0–0.3); there was no evidence of cognitive mediation of the clinical dose–response effects. Conclusions: These findings are novel in demonstrating that specific cognitive processes mediate clinical improvement with stimulant treatment for ADHD. They converge with work on ADHD theory, neurobiology, and treatment development in suggesting that inhibitory control and working memory may be mechanisms of stimulant treatment response in ADHD. More work is necessary to evaluate the degree to which these findings generalize to chronic treatment, a broader array of clinical outcomes, and nonstimulant treatments.

AB - Background: Stimulant medications such as methylphenidate (MPH) are the frontline treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). Despite their well-documented efficacy, the mechanisms by which stimulants improve clinical outcomes are not clear. The current study evaluated whether MPH effects on classroom behavior were mediated by improved cognitive functioning. Methods: Children with ADHD (n = 82; 9–12 years old) participated in a week-long summer research camp, consisting of cognitive testing, classroom periods, and recreational activities. After a baseline day, participants completed a 3-day randomized, double-blind, placebo-controlled trial of MPH (at doses approximating 0.3 and 0.6 mg/kg of immediate-release MPH dosed TID). Cognitive domains included inhibitory control (Stop Signal Task and prepulse inhibition of startle), attention (Continuous Performance Task and reaction time variability), and working memory (forward and backward spatial span). Clinical outcomes included math seatwork productivity and teacher-rated classroom behavior. A within-subjects path-analytic approach was used to test mediation. MPH-placebo and dose–response contrasts were used to evaluate drug effects. Results: Methylphenidate improved seatwork productivity and teacher ratings (ds = 1.4 and 1.1) and all domains of cognition (ds = 0.3–1.1). Inhibitory control (Stop Signal Task, SST) and working memory backward uniquely mediated the effect of MPH (vs. placebo) on productivity. Only working memory backward mediated the impact of MPH on teacher-rated behavior. The dose–response (0.6 vs. 0.3 mg/kg) effects were more modest for clinical outcomes (ds = 0.4 and 0.2) and cognition (ds = 0–0.3); there was no evidence of cognitive mediation of the clinical dose–response effects. Conclusions: These findings are novel in demonstrating that specific cognitive processes mediate clinical improvement with stimulant treatment for ADHD. They converge with work on ADHD theory, neurobiology, and treatment development in suggesting that inhibitory control and working memory may be mechanisms of stimulant treatment response in ADHD. More work is necessary to evaluate the degree to which these findings generalize to chronic treatment, a broader array of clinical outcomes, and nonstimulant treatments.

UR - http://www.scopus.com/inward/record.url?scp=85046545704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046545704&partnerID=8YFLogxK

U2 - 10.1111/jcpp.12917

DO - 10.1111/jcpp.12917

M3 - Article

VL - 59

SP - 1271

EP - 1281

JO - Journal of Child Psychology and Psychiatry and Allied Disciplines

JF - Journal of Child Psychology and Psychiatry and Allied Disciplines

SN - 0021-9630

IS - 12

ER -